TumorX Formulas Apoptosis Full Strength
Kill Cancer Cells
Tumorx Apoptosis Formulas treatment was found to result in a dose-dependent decrease in the viability of cancer cells. Normally, cancerous cells are unable to experience apoptosis by natural means. DNA (deoxyribonucleic acid) ladder assay demonstrated that, compared to vehicle-treated control, Tumorx Apoptosis Formulas treatment of squamous cell carcinoma resulted in an induction of programmed cell death as signaled by the nuclei in functioning cells.
This process is characterized by cleavage of the DNA into fragments that give a so called laddering pattern when the solid phase of the cell liquefies.
The induction of apoptosis by Tumorx Apoptosis Formulas was also especially clear when viewed with confocal microscopy (this microscope allows the observer to visualize objects in a single plane of focus, thereby creating a sharper image). This method identified the necrotic squamous cell carcinoma
TumorX Apoptosis Formula & DNA Cell Cycle Analysis
The DNA cell cycle analysis showed that sanguinarine treatment did not significantly affect the distribution of cells among the different phases of the cell cycle in squamous cell carcinoma. This is especially important because this proves definitely that Tumorx Apoptosis Formulas will not harm the DNA of cells. The research proves that Tumorx Apoptosis Formulas are effective anticancer formulas.
Agents that can eliminate the cancerous cells via a programmed cell death but do not affect the normal cells have a therapeutic advantage for the elimination of cancer cells. In contrast, TumorX Apoptosis Formulas will not harm the patient like synthetic allopathic drugs do.
Studies have shown that Tumorx Apoptosis Formulas are an inhibitor of the activation of nuclear transcription factor NF-B, which has been implicated to play a key role in the regulation of cell growth, cell cycle regulation, and apoptosis. The anti-tumor properties of Tumorx Apoptosis Formulas are constantly being reestablished.
Studies provide more definitive evidence that Tumorx Apoptosis Formulas at micromolar concentrations impart a cell growth-inhibitory response in human cancer cells via an induction of apoptosis.
Studies Demonstrated Success
Conducted by, Nihal Ahmad .et. al,. published by: Clinical Cancer Research Vol. 6, 1524-1528, April 2000. Demonstrated the following.
The effect of Tumorx Apoptosis Formulas and its anti-proliferative and apoptosis nature was investigated and the following found to be true:
1. Tumorx Apoptosis Formulas stops cancerous cells rapid growth.
2. Tumorx Apoptosis Formulas stops cancerous cells from abnormally increasing in number.
3. Tumorx Apoptosis Formulas stops the promotion of human epidermoid carcinoma cells, i.e., squamous cell (squamous cell is an invasive malignant tumor derived from epithelial tissue that tends to metastasize to other areas of the body).
4. Tumorx Apoptosis Formulas promotes the natural self-destruction (apoptosis) of cancer cells.
5. Tumorx Apoptosis Formulas will not promote apoptosis at any strength or concentration to healthy tissue.
The active ingredient in these two Formulas is derived from the root of Sanguinaria canadendid, a rare herb native to the Eastern U.S. and Canada. Tumorx Apoptosis Formulas are based upon the anticancer properties of the phytochemicals present.
Safety of TumorX Apoptosis Formulas
The concerns related to herbs with emetic potential are of primary significance when patients do not follow the TumorX Apoptosis Protocol.
When using Apoptosis Formulas one should follow and understand the TumorX Apoptosis Protocol.